EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

The Cannabinoid System as a Potential Novel Target for Alcohol‐Associated Liver Disease: A Propensity‐Matched Cohort Study

Butros Fakhoury iD, Vinay Jahagirdar, Kaanthi Rama, David Hudson, Wei Wang, Luis Antonio Díaz iD, Juan Pablo Arab iD

Liver International · 2025-11 · 45 (11)

DOI: 10.1111/liv.70401 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Liver International, online erschienen am 21.10.2025. Verfasst von Butros Fakhoury und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA. Hauptthemen laut MEDLINE: Marijuana Abuse, Liver Diseases, Alcoholic, Cannabidiol, Alcoholism. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alcohol‐associated liver disease (ALD) is a leading cause of liver‐related morbidity and mortality, yet effective therapeutic options remain limited. Preclinical data suggest that modulation of the hepatic endocannabinoid system, particularly via cannabidiol (CBD), may reduce alcohol‐induced liver injury. Due to CBD's limited clinical use, we sought to evaluate the association between cannabis use and ALD risk among patients with alcohol use disorder (AUD).

Methods

Using the TriNetX US Collaborative Network, we identified adult patients with AUD between 2010 and 2022. Three cohorts were constructed: cannabis use disorder (CUD), cannabis users without cannabis abuse or dependence (CU) and non‐cannabis users (non‐CU). Outcomes included ALD, hepatic decompensation and composite all‐cause mortality over 3 years. Incidence and hazard ratios were calculated using Kaplan–Meier analysis and Cox regression.

Results

After matching, 33 114 patients were included in each of the CUD and non‐CU groups. Compared to non‐CU, CUD was associated with a lower risk of ALD (HR 0.60, 95% CI 0.53–0.67; p < 0.001), hepatic decompensation (HR 0.83, 95% CI 0.73–0.95; p =0.005) and all‐cause mortality (HR 0.86, 95% CI 0.80–0.94; p < 0.001) among individuals with AUD. Although CU was associated with lower risks of ALD, its risks of hepatic decompensation and all‐cause mortality were similar to those of the non‐CU cohort with AUD.

Conclusion

In this propensity‐matched cohort study of patients with AUD, cannabis use was associated with a reduced risk of ALD, with the greatest risk reduction seen in patients with CUD compared to CU and non‐CU. Our findings suggest that modulation of cannabinoid receptors may offer a new target for the development of pharmacological therapies for ALD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Marijuana AbuseLiver Diseases, AlcoholicCannabidiolAlcoholismHumansMaleFemaleMiddle AgedAdultPropensity ScoreIncidenceProportional Hazards ModelsUnited StatesCohort StudiesKaplan-Meier EstimateCannabinoids

Stichwörter der Autor:innen

cannabidiolendocannabinoid systemfibrogenesishepatic stellate cellslipogenesis

Substanzen

CannabidiolCannabinoids

Autor:innen und Institutionen

  • Department of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virsginia, USA.
  • Division of Gastroenterology, Department of Medicine, Schulich School of Medicine, Western University & London Health Sciences Centre, London, Ontario, Canada.
  • Department of Medicine, St. Mary's Hospital, Waterbury, Connecticut, USA.
  • Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • MASLD Research Center, Division of Gastroenterology and Hepatology, University of California San Diego, San Diego, California, USA.

ORCID-Profile: Butros Fakhoury, Luis Antonio Díaz, Juan Pablo Arab

Zitieren

APA

Fakhoury, B., Jahagirdar, V., Rama, K., Hudson, D., Wang, W., Díaz, L. A., & Arab, J. P. (2025). The Cannabinoid System as a Potential Novel Target for Alcohol‐Associated Liver Disease: A Propensity‐Matched Cohort Study. Liver International, 45(11). https://doi.org/10.1111/liv.70401

Vancouver

Fakhoury B, Jahagirdar V, Rama K, Hudson D, Wang W, Díaz LA, et al. The Cannabinoid System as a Potential Novel Target for Alcohol‐Associated Liver Disease: A Propensity‐Matched Cohort Study. Liver International. 2025;45(11). doi:10.1111/liv.70401

BibTeX
@article{Fakhoury2025,
  author = {Fakhoury, Butros and Jahagirdar, Vinay and Rama, Kaanthi and Hudson, David and Wang, Wei and Díaz, Luis Antonio and Arab, Juan Pablo},
  title = {The Cannabinoid System as a Potential Novel Target for Alcohol‐Associated Liver Disease: A Propensity‐Matched Cohort Study},
  journal = {Liver International},
  year = {2025},
  volume = {45},
  number = {11},
  doi = {10.1111/liv.70401}
}
Kostenlos starten →